investorscraft@gmail.com

Intrinsic ValueRitamix Global Limited (1936.HK)

Previous CloseHK$0.71
Intrinsic Value
Upside potential
Previous Close
HK$0.71

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ritamix Global Limited operates as a specialized distributor and manufacturer of animal feed additives and human food ingredients, serving Malaysia's agricultural sector. The company's core revenue model combines product distribution with value-added technical services, including feed nutrition formulations, veterinary consultations, and technical support. This integrated approach creates multiple revenue streams while strengthening customer relationships. Ritamix caters primarily to poultry, swine, cattle, and aquaculture operations, offering essential products such as amino acids, vitamin premixes, acidifiers, enzymes, and organic antioxidants. The company's market position is strengthened by its 1982 founding, providing decades of sector expertise and established distribution networks. As a subsidiary of Garry-Worth Investment Limited, Ritamix maintains a focused regional presence in Malaysia's agricultural inputs market, competing through technical expertise and comprehensive product offerings rather than scale.

Revenue Profitability And Efficiency

The company generated HKD 122.5 million in revenue with net income of HKD 8.3 million, reflecting a net margin of approximately 6.8%. Operating cash flow was negative HKD 0.3 million, while capital expenditures totaled HKD 2.7 million, indicating potential investments in manufacturing capabilities. The diluted EPS of HKD 0.0176 demonstrates modest earnings generation relative to the share count.

Earnings Power And Capital Efficiency

Ritamix demonstrates moderate earnings power with HKD 8.3 million net income, though negative operating cash flow raises questions about working capital management. The company maintains capital efficiency through its distribution-focused model, requiring limited manufacturing assets. The negative beta of -0.273 suggests defensive characteristics, potentially insulating earnings from broader market movements.

Balance Sheet And Financial Health

The balance sheet appears robust with HKD 60.3 million in cash against minimal total debt of HKD 1.9 million, indicating strong liquidity and low leverage. This conservative financial structure provides flexibility for operational needs and potential expansion. The substantial cash position relative to market capitalization suggests financial stability.

Growth Trends And Dividend Policy

The company maintains a shareholder-friendly approach with a dividend per share of HKD 0.11, which significantly exceeds the diluted EPS, indicating a substantial payout ratio. This suggests either special distributions or sustainable dividend coverage through retained earnings. Growth appears modest given the current revenue base and market positioning within Malaysia's agricultural sector.

Valuation And Market Expectations

With a market capitalization of approximately HKD 298.7 million, the company trades at a P/E ratio around 36 based on current earnings. The generous dividend yield, supported by the strong cash position, likely reflects market expectations for stable returns rather than aggressive growth, aligning with its defensive sector characteristics.

Strategic Advantages And Outlook

Ritamix benefits from deep industry expertise, established customer relationships, and technical service capabilities that differentiate it from pure distributors. The outlook depends on Malaysia's agricultural sector performance and the company's ability to maintain its value-added service model while managing working capital efficiency to improve cash flow generation.

Sources

Company financial reportsHong Kong Stock Exchange filingsMarket data providers

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount